...
首页> 外文期刊>Lancet Neurology >Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study
【24h】

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study

机译:那他珠单抗治疗的多发性硬化症患者对JC病毒的免疫反应:横断面和纵向研究

获取原文
获取原文并翻译 | 示例

摘要

Background Natalizumab is used to prevent relapses and progression of disability in patients with multiple sclerosis but has been associated with progressive multifocal leukoencephalopathy (PML). We aimed to better understand the associations between JC virus, which causes PML, and natalizumab treatment.
机译:背景纳他珠单抗用于预防多发性硬化症患者的复发和残疾发展,但已与进行性多灶性白质脑病(PML)相关。我们旨在更好地了解导致PML的JC病毒与那他珠单抗治疗之间的关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号